Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Eva P, Galiza"'
Autor:
Paul T Heath, Eva P Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Fiona Burns, David R Chadwick, Rebecca Clark, Catherine A Cosgrove, James Galloway, Anna L Goodman, Amardeep Heer, Andrew Higham, Shalini Iyengar, Christopher Jeanes, Philip A Kalra, Christina Kyriakidou, Judy M Bradley, Chigomezgo Munthali, Angela M Minassian, Fiona McGill, Patrick Moore, Imrozia Munsoor, Helen Nicholls, Orod Osanlou, Jonathan Packham, Carol H Pretswell, Alberto San Francisco Ramos, Dinesh Saralaya, Ray P Sheridan, Richard Smith, Roy L Soiza, Pauline A Swift, Emma C Thomson, Jeremy Turner, Marianne Elizabeth Viljoen, Louis Fries, Iksung Cho, Irene McKnight, Greg Glenn, E Joy Rivers, Andreana Robertson, Katia Alves, Kathy Smith, Seth Toback
Publikováno v:
Clinical Infectious Diseases. 76:398-407
Background The recombinant protein-based vaccine, NVX-CoV2373, demonstrated 89.7% efficacy against coronavirus disease 2019 (COVID-19) in a phase 3, randomized, observer-blinded, placebo-controlled trial in the United Kingdom. The protocol was amende
Autor:
Paul T, Heath, Eva P, Galiza, David Neil, Baxter, Marta, Boffito, Duncan, Browne, Fiona, Burns, David R, Chadwick, Rebecca, Clark, Catherine A, Cosgrove, James, Galloway, Anna L, Goodman, Amardeep, Heer, Andrew, Higham, Shalini, Iyengar, Christopher, Jeanes, Philip A, Kalra, Christina, Kyriakidou, Judy M, Bradley, Chigomezgo, Munthali, Angela M, Minassian, Fiona, McGill, Patrick, Moore, Imrozia, Munsoor, Helen, Nicholls, Orod, Osanlou, Jonathan, Packham, Carol H, Pretswell, Alberto San, Francisco Ramos, Dinesh, Saralaya, Ray P, Sheridan, Richard, Smith, Roy L, Soiza, Pauline A, Swift, Emma C, Thomson, Jeremy, Turner, Marianne Elizabeth, Viljoen, Louis, Fries, Iksung, Cho, Irene, McKnight, Greg, Glenn, E Joy, Rivers, Andreana, Robertson, Katia, Alves, Kathy, Smith, Seth, Toback
Publikováno v:
Heath, P T, Galiza, E P, Baxter, D N, Boffito, M, Browne, D, Burns, F, Chadwick, D R, Clark, R, Cosgrove, C A, Galloway, J, Goodman, A L, Heer, A, Higham, A, Iyengar, S, Jeanes, C, Kalra, P A, Kyriakidou, C, Bradley, J M, Munthali, C, Minassian, A M, McGill, F, Moore, P, Munsoor, I, Nicholls, H, Osanlou, O, Packham, J, Pretswell, C H, Francisco Ramos, A S, Saralaya, D, Sheridan, R P, Smith, R, Soiza, R L, Swift, P A, Thomson, E C, Turner, J, Viljoen, M E, Fries, L, Cho, I, McKnight, I, Glenn, G, Rivers, E J, Robertson, A, Alves, K, Smith, K & Toback, S 2023, ' Safety and efficacy of the NVX-CoV2373 COVID-19 vaccine at completion of the placebo-controlled phase of a randomized controlled trial ', Clinical Infectious Diseases, vol. 76, no. 3, pp. 398–407 . https://doi.org/10.1093/cid/ciac803
BackgroundThe recombinant protein-based vaccine, NVX-CoV2373, demonstrated 89.7% efficacy against coronavirus disease 2019 (COVID-19) in a phase 3, randomized, observer-blinded, placebo-controlled trial in the United Kingdom. The protocol was amended
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ceb2e01b1f99b5599959da54ff0d03b3
https://pure.qub.ac.uk/en/publications/fa36d917-7502-4c1b-801a-d654b01a7457
https://pure.qub.ac.uk/en/publications/fa36d917-7502-4c1b-801a-d654b01a7457
Publikováno v:
Medicine. 49:739-742
Autor:
Robert H Shaw, Xinxue Liu, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, J Claire Cameron, Sue Charlton, Elizabeth A Clutterbuck, Andrea M Collins, Wanwisa Dejnirattisai, Tanya Dinesh, Saul N Faust, Daniela M Ferreira, Adam Finn, Christopher A Green, Bassam Hallis, Paul T Heath, Helen Hill, Teresa Lambe, Rajeka Lazarus, Vincenzo Libri, Fei Long, Yama F Mujadidi, Emma L Plested, Ella R Morey, Samuel Provstgaard-Morys, Maheshi N Ramasamy, Mary Ramsay, Robert C Read, Hannah Robinson, Gavin R Screaton, Nisha Singh, David P J Turner, Paul J Turner, Iason Vichos, Laura L Walker, Rachel White, Jonathan S Nguyen-Van-Tam, Matthew D Snape, Alasdair P.S. Munro, Jazz Bartholomew, Laura Presland, Sarah Horswill, Sarah Warren, Sophie Varkonyi-Clifford, Stephen Saich, Kirsty Adams, Marivic Ricamara, Nicola Turner, Nicole Y. Yee Ting, Sarah Whittley, Tommy Rampling, Amisha Desai, Claire H. Brown, Ehsaan Qureshi, Karishma Gokani, Kush Naker, Johanna K. Kellett Wright, Rachel L. Williams, Tawassal Riaz, Florentina D. Penciu, Amy Carson, Claudio Di Maso, Gracie Mead, Elizabeth G. Howe, Mujtaba Ghulam Farooq, Rabiullah Noristani, Xin L. Yao, Neil J. Oldfield, Daniel Hammersley, Sue Belton, Simon Royal, Alberto San Francisco Ramos, Cecilia Hultin, Eva P. Galiza, Rebecca Crook, Marcin Bula, Fred Fyles, Hassan Burhan, Flora Maelin, Elen Hughes, Emmanuel Okenyi
Publikováno v:
Shaw, R H, Liu, X, Stuart, A S V, Greenland, M, Aley, P K, Andrews, N J, Finn, A & Lazarus, R & et, A 2022, ' Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules : exploratory analyses of Com-COV, a randomised control trial ', Lancet Respiratory Medicine, vol. 10, no. 11, pp. 1049-1060 . https://doi.org/10.1016/S2213-2600(22)00163-1
Background Priming COVID-19 vaccine schedules have been deployed at variable intervals globally, which might influence immune persistence and the relative importance of third-dose booster programmes. Here, we report exploratory analyses from the Com-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed4ea510bf1be44fbc2afbfb9cf0590
https://eprints.soton.ac.uk/456454/
https://eprints.soton.ac.uk/456454/
Autor:
Helen Ratcliffe, K S Tiley, Nick Andrews, Gayatri Amirthalingam, I Vichos, E Morey, N L Douglas, S Marinou, Emma Plested, Parvinder Aley, Eva P Galiza, Saul N Faust, S Hughes, Clare S Murray, Marion Roderick, Fiona Shackley, Sam J Oddie, Tim Lees, D P J Turner, M Raman, Stephen Owens, Paul Turner, H Cockerill, J Lopez Bernal, E Linley, Ray Borrow, Kevin Brown, Mary Elizabeth Ramsay, M Voysey, Matthew D Snape
ObjectiveTo understand community seroprevalence of SARS-CoV-2 in children and adolescents. This is vital to understanding the susceptibility of this cohort to COVID-19 and to inform public health policy for disease control such as immunisation.Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cea6fc8605228eb685ecc07b762ed77
http://hdl.handle.net/10044/1/98477
http://hdl.handle.net/10044/1/98477
Autor:
Nana-Marie Lemm, Sabina Ikram, Jessica Poppy Jane Larwood, Katherine R. W. Emary, Saul N. Faust, Savviz Mehdipour, Rajeka Lazarus, Hazel Morrison, Robert Shaw, Michael Schumacher, Katarina M Pollock, Poppy Iveson, Paul T. Heath, Mihaela Pacurar, Eva P. Galiza, Daniel R Owens, Susanne H. Hodgson, Catherine Cosgrove, Sophie Roche, Andrew J. Pollard
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 15, Iss 2, Pp 524-534 (2022)
Hodgson, S H, Iveson, P, Larwood, J, Roche, S, Morrison, H, Cosgrove, C, Galiza, E, Ikram, S, Lemm, N-M, Mehdipour, S, Owens, D, Pacurar, M, Schumacher, M, Shaw, R H, Faust, S N, Heath, P T, Pollard, A J, Emary, K R W, Pollock, K M & Lazarus, R 2022, ' Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial ', Clinical and Translational Science, vol. 15, no. 2, pp. 524-534 . https://doi.org/10.1111/cts.13170
Clinical and Translational Science, Vol 15, Iss 2, Pp 524-534 (2022)
Hodgson, S H, Iveson, P, Larwood, J, Roche, S, Morrison, H, Cosgrove, C, Galiza, E, Ikram, S, Lemm, N-M, Mehdipour, S, Owens, D, Pacurar, M, Schumacher, M, Shaw, R H, Faust, S N, Heath, P T, Pollard, A J, Emary, K R W, Pollock, K M & Lazarus, R 2022, ' Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial ', Clinical and Translational Science, vol. 15, no. 2, pp. 524-534 . https://doi.org/10.1111/cts.13170
The safety of novel therapeutics and vaccines are typically assessed in early phase clinical trials involving “healthy volunteers.” Abnormalities in such individuals can be difficult to interpret and may indicate previously unrecognized medical c
Autor:
Jordan R. Barrett, Adam Finn, Julie Furze, Rajeka Lazarus, Robert Aley, Emma Plested, Nicholas Byard, Alison M. Lawrie, Jack E. Saunders, Catherine C. Smith, Katie J. Ewer, Hannah Davies, Amber Thompson, Jonathan Kwok, Danielle Woods, Luke Blackwell, M N Ramasamy, Wanwisa Dejnirattisai, Hannah Roberts, Conor Whelan, Elizabeth F Jones, Vincenzo Libri, Mutjaba Ghulam Farooq, D Jenkin, D Bellamy, Mimi M. Hou, Alexander D. Douglas, Sarah Kelly, Adrian V. S. Hill, Sarah C. Gilbert, Christine S. Rollier, Megan Baker, Matthew Rajan, Liaquat Khan, E. Thomson, Amy Boyd, Rebecca Beckley, Phillip Baker, Stanislava Koleva, Louise Bates, Simon Kerridge, David J. Smith, Emma Francis, Christina Dold, Brian Angus, Christopher J A Duncan, Raquel Lopez Ramon, Andrew Smith, Alice Bridges-Webb, Thomas C. Hart, R Song, O Mazur, L Silva-Reyes, Claudio Di Maso, Rabiullah Noristani, Patrick J. Lillie, Marco Polo Peralta Alvarez, Matthew D. Snape, Wendy E.M. Crocker, Patrick Kinch, Charles H. Brown, Jasmin Kinch, Angela M. Minassian, M Bittaye, Jilly Muller, Emma V. Sheehan, J Aboagye, Anna L. Goodman, Iain Turnbull, Julia L. Marshall, Kirsten Beadon, Tanya Dinesh, R Makinson, Hannah Sharpe, Indra Rudiansyah, Jade Keen, Yama F Mujadidi, Laura L. Walker, Marta Ulaszewska, Baktash Khozoee, Jonathan Bell, Cameron Bissett, Robert Shaw, E Howe, Amy Beveridge, Cheryl Turner, Holly Smith, Karly Tang, Federica Cappuccini, Syed Adlou, Juthathip Mongkolsapaya, Estée M. Török, Spyridoula Marinou, Joanne McEwan, Rachel Cooper, David P. J. Turner, Merin Thomas, Tonia M. Thomas, Nicola Greenwood, Gavin R. Screaton, Sally Felle, S Bibi, Carla Ferreira Da Silva, P M Folegatti, Jolynne Mokaya, Sophia Hawkins, Elizabeth A. Clutterbuck, Ian D. Poulton, Andy Yao, Reece Mabbett, Christopher A Green, Emma Marlow, Mark Toshner, Heather Bletchly, Alexandra J. Spencer, Rebecca K. Sutherland, Leila Godfrey, Eva P. Galiza, Sarah Williams, Andrew J. Pollard, Saul N. Faust, Grace Li, Mwila Kasanyinga, Nicola Howell, Aabidah Ali, Daisy Harrison, Thomas C. Darton, Samiullah Seddiqi, David J. Kerr, Gertraud Morshead, Rachael Drake-Brockman, Aline Linder, Jamie Fowler, Sandra Belij-Rammerstorfer, Susana Camara, Colin W. Larkworthy, Sophie Davies, Marion E. Watson, Parvinder K. Aley, Bryn Horsington, Sean C. Elias, Adam J. Ritchie, Nelly Owino, David Pulido-Gomez, Michelle Fuskova, Alastair McGregor, Hannah Robinson, Fei Long, Rachel Anslow, Karen J. Ford, Daniela M. Ferreira, Katherine R. W. Emary, Ella Morey, Amy Flaxman, Paul T. Heath, Katrina M Pollock, Liliana Cifuentes Gutierrez, Samuel Provstgaard-Morys, Arabella Stuart, Helen Sanders, Anna Szigeti, Rachel White, Francesca R. Donnellan, Catherine M. Green, Katherine Sanders, N G Marchevsky, Andrea M. Collins, Merryn Voysey, Kushalinii Hillson, Teresa Lambe, Philomena Mweu, Chris Williams, Iason Vichos, Daniel B. Wright, Carina Citra Dewi Joe, Tesfaye Demissie, Rose Trivett, Richard Morter, Helen Hill, Judith Davies, Emily A. Lees, Nisha Singh, Ana Gibertoni Cruz, P Cicconi, Abigail Platt, Fernando Ramos Lopez, Nguyen Tran
Publikováno v:
Lancet (London, England)
Background COVID-19 vaccine supply shortages are causing concerns about compromised immunity in some countries as the interval between the first and second dose becomes longer. Conversely, countries with no supply constraints are considering administ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9942f9b6ea936cc7be0ba9e053573ebf
http://hdl.handle.net/10044/1/92023
http://hdl.handle.net/10044/1/92023
Autor:
Paul T. Heath, Kirsty Le Doare, Anna M. Calvert, Suzy Lim, Eva P. Galiza, Asma Khalil, Melanie Etti
Publikováno v:
American Journal of Obstetrics and Gynecology
Maternal vaccination is an effective means of protecting pregnant women, their fetuses and infants from vaccine-preventable infections. Despite the availability of sufficient safety data to support the use of vaccines during pregnancy, maternal immun
Autor:
Sophie Varkonyi-Clifford, Sue Charlton, Anna England, Matthew D. Snape, Parvinder K. Aley, Elizabeth A. Clutterbuck, Pauline Ambrose, Eva P. Galiza, Adam Finn, Laura L. Walker, Emma Plested, Ehsaan Qureshi, Chanice Knight, David P. J. Turner, Lisa Hitchins, Mujtaba Ghulam Farooq, Christopher A Green, Melanie Greenland, J. Claire Cameron, Stephanie Leung, Karen Buttigieg, Jonathan S. Nguyen-Van-Tam, Cecilia Hultin, Florentina D Penciu, Jazz Bartholomew, Yama F Mujadidi, Nisha Singh, Sarah Horswill, Tommy Rampling, Kush Naker, Rabiullah Noristani, Xinxue Liu, Marivic Ricamara, Tawassal Riaz, Phill Brown, Rajeka Lazarus, Imam Shaik, Johanna K Kellett Wright, Kerry Godwin, Kelly Davies, Robert Shaw, Paminder Lall, Neil J. Oldfield, Farah Shiham, Sue Belton, Karishma Gokani, Carla Solórzano, Mary Ramsay, Kirsty Adams, Ross Fothergill, Hannah Robinson, Claudio Di Maso, Rachel Williams, Lauren Allen, Paul T. Heath, Sarah Whittley, Stephen Saich, E Howe, Bassam Hallis, Alberto San Francisco Ramos, Simon Royal, Alasdair Munro, Tanya Dinesh, Vincenzo Libri, Helen Hill, Arabella Stuart, Samuel Provstgaard-Morys, Xin L Yao, Andrea M. Collins, Rachel White, Paul Turner, Teresa Lambe, Nick Andrews, Iason Vichos, Daniela M. Ferreira, Natalie Baker, Nicole Y Yee Ting, Claire Brown, M N Ramasamy, Sarah Warren, Amisha Desai, Fei Long, Laura Presland, Hannah Sainsbury, Daniel Hammersley, Saul N. Faust, Robert C. Read, Nicola Turner
Publikováno v:
Lancet (London, England)
Snape, M D 2021, ' Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV) : a single-blind, randomised, non-inferiority trial ', Lancet, vol. 398, no. 10303, pp. 856-869 . https://doi.org/10.1016/S0140-6736(21)01694-9
Snape, M D 2021, ' Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV) : a single-blind, randomised, non-inferiority trial ', Lancet, vol. 398, no. 10303, pp. 856-869 . https://doi.org/10.1016/S0140-6736(21)01694-9
Background Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate mass COVID-19 immunisation. However, we have previously reported that heterologous schedules incorporating an adenoviral vectored vaccine (ChAdOx1 nCoV-19, AstraZe
Autor:
E. Joy Rivers, Lakshmi Kumar, Sankarasubramanian Rajaram, Paul T. Heath, Angela M. Minassian, Catherine Cosgrove, Iksung Cho, Greg Glenn, Anna Goodman, Eva P. Galiza, Filip Dubovsky, Joyce S Plested, Alison Graves-Jones, Jonathan Edelman, Fiona Burns, James Galloway, Pauline A Swift, Seth Toback, Andreana Robertson
SummaryBackgroundThe safety and immunogenicity profile of COVID-19 vaccines when administered concomitantly with seasonal influenza vaccines has not yet been reported.MethodsA sub-study on influenza vaccine co-administration was conducted as part of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c71a0e423eb3ee8cf20e5f5ce4e60141
https://doi.org/10.1101/2021.06.09.21258556
https://doi.org/10.1101/2021.06.09.21258556